EICHORCondition: Arteriovenous Fistula · Sponsor: C. R. Bard
This prospective, global, multicenter, single arm post-approval study is designed to investigate the clinical use and safety of the Lutonix® 035 AV Drug Coated Balloon (DCB) PTA Catheter in subjects presenting with clinical and hemodynamic abnormalities in native arteriovenous (AV) fistulae located in the upper extremity.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | — |
| Flowers Hospital | Dothan, Alabama, United States | — |
| St. Joseph Hospital of Orange | Orange, California, United States | — |
| Kaiser Permanente | San Diego, California, United States | — |
| Yale University | New Haven, Connecticut, United States | — |
| University of Iowa Hospital and Clinics | Iowa City, Iowa, United States | — |
| University of Louisville | Louisville, Kentucky, United States | — |
| Ochsner Health System | New Orleans, Louisiana, United States | — |
| Ochsner Louisiana State University Health | Shreveport, Louisiana, United States | — |
| MedStar Health Research Institute | Annapolis, Maryland, United States | — |
| Beth Israel Deaconess Medical Center | Boston, Massachusetts, United States | — |
| University of Michigan | Ann Arbor, Michigan, United States | — |
+ 14 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03506308